EXL 33.3% 0.4¢ elixinol wellness limited

Reported today in New Atlas (from Lancet Public Health, by the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,285 Posts.
    lightbulb Created with Sketch. 513
    Reported today in New Atlas (from Lancet Public Health, by the Australian National Drug and Alcohol Research Centre, UNSW, Sydney).

    It highlights the problems for medical cannabis research (and use) in Australia compared to Canada, the USA and Germany.

    Yet another example of why EXL should concentrate on it's Hemp USA operations, and use company funds for USA expansion, and not get too caught up in costly long-term medical cannabis research in Australia. There is not going to be any money in it for decades.

    (A purportedly flawed) controversial Australian study finds no evidence that cannabis helps chronic pain.
    https://newatlas.com/australian-cannabis-chronic-pain-study/55298/

    Everyone knows it does, from thousands of studies overseas.

    I would like to know who funded the Australian study, my bet is big pharma.

    Anyway, the conclusion reached by the medical journalist was as follows;

    " In Australia, medical cannabis usage was only approved for a very limited number of conditions in 2016. While the United States and Canada are moving to more broadly allow recreational usages of the drug, Australia is moving much more slowly and conservatively. Despite the disappointing limitations of this study, and its conclusions being inconsistent with broader international research, it may slow down further medical cannabis legislation in the country (of Australia) over the coming years. "

    Gw
 
watchlist Created with Sketch. Add EXL (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.002(33.3%)
Mkt cap ! $6.605M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $2.103K 475.4K

Buyers (Bids)

No. Vol. Price($)
17 7670493 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 924824 4
View Market Depth
Last trade - 14.04pm 29/11/2024 (20 minute delay) ?
EXL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.